<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=737250381714742&amp;ev=PageView&amp;noscript=1">
header art

News

PHARMACEUTICAL CONTRACT PACKAGING UPDATES

Aphena to Host a Suite at DCAT Week March 16-19 in NYC

Aphena to Host a Suite at DCAT Week March 16-19 in NYC

March 2015

COOKEVILLE, Tenn. — Eric Allen and Paul Glintenkamp of Aphena Pharma Solutions are currently scheduling times to meet with industry colleagues, customers and prospective new clients during DCAT Week, set for March 16-19 in New York City. For the event, Aphena has reserved a business meeting suite where our representatives and guests can discuss packaging and manufacturing needs as well as strategies for development and implementation for serialization....

More
Aphena to Exhibit at GPhA Annual Meeting Business Exposition

Aphena to Exhibit at GPhA Annual Meeting Business Exposition

February 2015

COOKEVILLE — Eric Allen and Paul Glintenkamp of Aphena Pharma Solutions will be exhibiting at the Generic Pharmaceutical Association (GPhA) Annual Business Expo, set for Feb. 9-11 at the Fontainebleau Miami Beach in Miami Beach, Florida. We'll be meeting with our customers and prospective new clients to learn about their business models and their packaging and manufacturing needs, as well as to discuss strategies for development and implementation for serialization....

More
Aphena Adds Fourth Bottle Line to New Jersey Facility

Aphena Adds Fourth Bottle Line to New Jersey Facility

December 2014

TREVOSE, Pa., Dec. 2, 2014 — Aphena Pharma Solutions recently installed a new bottling line in our Whippany, New Jersey, facility to add to our offerings for contract packaging. Aphena now has four bottle lines in our New Jersey site to complement the six bottle lines we have in our Cookeville, Tennessee, location....

More
Aphena's DEA Class II packaging and storage capabilities provide value with new FDA/DEA regulations

Aphena's DEA Class II packaging and storage capabilities provide value with new FDA/DEA regulations

September 2014

As many in the pharmaceutical industry are aware, recent revisions to DEA regulations effective October 6, 2014, require reclassification of hydrocodone products from Class III to Class II....

More
Aphena Obtains $10 Million in Financing from NewStar

Aphena Obtains $10 Million in Financing from NewStar

March 2014

Aphena Pharma Solutions and subsidiaries ("Aphena") announced today that it has obtained a revolving credit facility totaling $10,000,000 from NewStar Business Credit, a wholly-owned subsidiary of NewStar Financial, Inc. (NASDAQ: NEWS). The revolving credit facility will be used by Aphena to refinance existing debt and support future growth....

More
Aphena Shares Its Successful Track-and-Trace Guidelines in New White Paper

Aphena Shares Its Successful Track-and-Trace Guidelines in New White Paper

September 2013

At Aphena Pharma Solutions, we have developed a step-by-step process that has helped us successfully establish our track-and-trace program. We have outlined this procedure in a white paper titled A Step-by-Step Guide to Implement Track and Trace, which you can view and/or download by clicking here....

More
Aphena Pharma Solutions Featured On Pharmaceutical Online

Aphena Pharma Solutions Featured On Pharmaceutical Online

May 2013

In a recent article featured on Pharmaceutical Online, David A. Loy, the Senior Director of Quality and Regulatory Affairs at Aphena Pharma Solutions, discusses the strategy for a national standardization for drug serialization....

More
Aphena Pharma Solutions Supports Highlands Initiative in Tennessee

Aphena Pharma Solutions Supports Highlands Initiative in Tennessee

February 2012

PHILADELPHIA, Pa. - Philadelphia-based Aphena Pharma Solutions, a leading pharmaceutical packaging provider in the U.S. with a manufacturing facility in Cookeville, Tenn., has recently made a major investment in support of the Highlands Initiative, a strategic alliance between Jackson, Overton, Putnam and White counties in Tennessee....

More